RAGGI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 3.561
AS - Asia 2.665
EU - Europa 2.415
SA - Sud America 389
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 50
OC - Oceania 32
Totale 9.236
Nazione #
US - Stati Uniti d'America 3.469
RU - Federazione Russa 965
CN - Cina 813
SG - Singapore 745
IT - Italia 627
HK - Hong Kong 303
BR - Brasile 302
KR - Corea 268
VN - Vietnam 230
IE - Irlanda 173
PL - Polonia 147
SE - Svezia 133
IN - India 93
FR - Francia 83
DE - Germania 76
FI - Finlandia 61
CA - Canada 45
GB - Regno Unito 40
AR - Argentina 37
ID - Indonesia 33
AU - Australia 31
JP - Giappone 27
BD - Bangladesh 25
NL - Olanda 23
JO - Giordania 22
EC - Ecuador 20
IQ - Iraq 17
ES - Italia 13
UA - Ucraina 13
TR - Turchia 12
MX - Messico 11
TW - Taiwan 11
ZA - Sudafrica 11
MK - Macedonia 10
AT - Austria 9
CH - Svizzera 9
CO - Colombia 9
PH - Filippine 9
NG - Nigeria 8
IR - Iran 7
KZ - Kazakistan 7
CI - Costa d'Avorio 6
EG - Egitto 6
PK - Pakistan 6
CL - Cile 5
CR - Costa Rica 5
JM - Giamaica 5
LK - Sri Lanka 5
NI - Nicaragua 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BJ - Benin 4
KE - Kenya 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
TH - Thailandia 4
BO - Bolivia 3
EE - Estonia 3
HN - Honduras 3
LB - Libano 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BE - Belgio 2
BS - Bahamas 2
BZ - Belize 2
HU - Ungheria 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
SN - Senegal 2
SV - El Salvador 2
UY - Uruguay 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
LC - Santa Lucia 1
Totale 9.104
Città #
Santa Clara 1.040
Singapore 590
Ashburn 480
Hefei 285
Seoul 265
Hong Kong 249
San Jose 207
Dublin 172
Warsaw 147
Milan 119
Fairfield 116
Florence 96
Chandler 86
Beijing 84
Los Angeles 82
Council Bluffs 74
Ho Chi Minh City 65
Altamura 62
Hanoi 62
Lawrence 62
Rome 60
Houston 57
Moscow 57
Seattle 54
Lauterbourg 50
Buffalo 48
Kent 48
The Dalles 48
Cambridge 40
Wilmington 39
Woodbridge 37
Dallas 35
Phoenix 35
Princeton 32
Melbourne 31
Boston 30
Helsinki 30
New York 25
Munich 24
São Paulo 24
Mumbai 23
Shanghai 23
Tokyo 23
Chicago 21
Jakarta 21
Bengaluru 19
San Diego 19
Ann Arbor 17
Turku 16
West Jordan 16
Atlanta 15
Paris 15
Frankfurt am Main 14
Lappeenranta 14
Boardman 13
Figino 13
Naples 12
Turin 12
Falkenstein 11
London 11
Modena 11
Philadelphia 11
Charlotte 10
Da Nang 10
Dong Ket 10
Guangzhou 10
Guayaquil 10
Haiphong 9
Abuja 8
Belo Horizonte 8
Brooklyn 8
Medford 8
Orem 8
Rio de Janeiro 8
Istanbul 7
Pune 7
San Francisco 7
Toronto 7
Abidjan 6
Baghdad 6
Bologna 6
Cairo 6
Curitiba 6
Montreal 6
Palermo 6
Quito 6
Washington 6
Amsterdam 5
Brasília 5
Clifton 5
Colombo 5
Fortaleza 5
Hangzhou 5
Managua 5
Miano 5
Shenzhen 5
Zurich 5
Almaty 4
Baku 4
Bari 4
Totale 5.748
Nome #
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 345
Organoids and spheroids: advanced in vitro models for liver cancer research. 237
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 235
The role of stroma in cholangiocarcinoma: The intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium 220
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 210
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 209
Fatty acids regulate the biology of cholangiocarcinoma cells 209
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 201
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 201
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 199
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 196
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 196
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 193
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives 191
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 185
Role of chemokines in the biology of cholangiocarcinoma 184
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 181
Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16 177
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 169
Metabolic reprogramming in cholangiocarcinoma 167
The role of the hedgehog pathway in cholangiocarcinoma 155
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 153
A novel multidrug‐resistant cell line from an italian intrahepatic cholangiocarcinoma patient 150
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells 149
3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma Cells 147
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma 147
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 143
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma 142
Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 142
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. 137
Assessment of a high sensitivity method for identification of IDH1 R132x mutations in tumors and plasma of Intrahepatic Cholangiocarcinoma patients 129
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2 128
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types 128
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer 123
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line resistant to gemcitabine 123
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the β-cell line INS-1E 123
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. 120
Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity 119
An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer. 118
Epigenetic reprogramming modulates malignant properties of human liver cancer 118
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus. 117
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages 116
RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines 115
More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma 113
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma 113
Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. 112
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 112
Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 111
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts 111
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma 111
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 110
Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 108
Mesenchymal stem cells, aging and regenerative medicine. 107
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma 105
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 102
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. 101
Cholangiocarcinoma 2026: status quo, unmet needs and priorities. 100
Iron metabolism in liver cancer stem cells 99
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 98
Methylation and liver cancer 93
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies 87
A novel naphthoquinone compound triggers DNA damage-induced apoptosis on cholangiocarcinoma through upregulation of BAX 79
The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma 73
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome 35
GLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinoma 9
Totale 9.236
Categoria #
all - tutte 26.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 0 0 3 8 4 15 1 17 63 15 28 75
2022/2023613 62 166 51 16 14 105 84 37 52 4 12 10
2023/2024422 11 30 41 30 31 40 19 101 16 35 60 8
2024/20252.970 69 277 145 430 878 352 135 77 156 81 138 232
2025/20263.926 411 566 545 456 347 127 429 180 194 248 116 307
2026/2027469 149 115 205 0 0 0 0 0 0 0 0 0
Totale 9.236